Device Trauma

Tfn-Advance

Payments companies reported to CMS as associated with Tfn-Advance. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$723Kassociated payments (2023-2025)

1,972clinicians with associated payments

5companies reporting

By year

2023 $174K

2024 $221K

2025 $328K

Payments reported as associated with Tfn-Advance, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Trauma $389K

Orthopaedic Surgery $265K

Physician Assistant $8,415

Sports Medicine (Orthopaedic Surgery) $7,875

Adult Reconstructive Orthopaedic Surgery $4,966

Hand Surgery $4,484

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Tfn-Advance

These are the largest totals companies reported as associated with Tfn-Advance. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Sean Nork	Seattle, WA	Orthopaedic Trauma	$97,548.13
Eben Carroll	Winston Salem, NC	Orthopaedic Surgery	$56,686.18
Paul Gladden	New Orleans, LA	Orthopaedic Trauma	$51,819.38
Greg Osgood	Baltimore, MD	Orthopaedic Trauma	$50,883.80
Murphy Martin	New Orleans, LA	Orthopaedic Trauma	$31,739.14
Mark Lee	Sacramento, CA	Orthopaedic Trauma	$27,931.90
Raymond Wright Jr	Lexington, KY	Orthopaedic Trauma	$24,129.10
Stephen Stacey	Golden, CO	Orthopaedic Surgery	$19,088.21
George Russell	Jackson, MS	Orthopaedic Trauma	$17,895.18
Cory Collinge	Fort Worth, TX	Orthopaedic Trauma	$16,393.80

Prescribed Tfn-Advance?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.